|Number of samples:||24|
|Release date:||Mar 22 2018|
|Last update date:||Nov 29 2018|
|Dataset link||HIV-1 infection of human monocyte-derived dendritic cells with and without the integrase inhibitor, Raltegravir (ATAC-Seq).|
DCs were derived from the peripheral blood from three deidentified human donors and infected with a single-cycle HIV-1 reporter virus (HIV-GFP) in the presence of Vpx, with and without Raltegravir. At 0, 16, 32, and 48 hours after infection, live cells were sorted and then prepped for an Assay for Transposase-Accessible Chromatin with high-throughput Sequencing (ATAC-Seq).